...
Dive | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
|
He became Chief chief of the Laboratory of Viral Immunology in DBS in 1964. Dr. Meyer moved to Building 29A Overview after it opened in 1967, working on the second floor with the Laboratory of Viral Immunology.
Dr. Meyer worked with Dr. Parkman on the first rubella vaccine beginning in 1964 and the new rubella antibody test (patented in 1971).
With the administrative transition of the DBS from the NIH to the Food and Drug Administration (FDA) in 1972, Dr. Meyer became the Director director of what was then called the Bureau of Biologics. He stayed in this role from 1972 until he retired in 1986. Under Meyer’s leadership, the FDA biologics team initiated review of all licensed biologics for safety, effectiveness, and labeling, ; they developed techniques to assess allergenic product activities, ; and they licensed the first AIDS test kit. When he retired, biologics was called the FDA Center for Drugs and Biologics; by 1987, it would become the FDA Center for Biologics Evaluation and Research (CBER), which is the name it maintains to this day.
Dr. Meyer was the recipient of several awards during his career including: the FDA Award of Merit, the FDA Commissioner’s Special Citation, the Public Health Service Meritorious Service Award, and the Chevalier de l’Ordre National of the Republic of Upper Volta (West Africa) in 1963 for his work on the measles vaccine, and he . He also received a letter of commendation from President Lyndon B. Johnson.
...
Dive | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||
|